Close Menu

NEW YORK, Feb 27 – Illumina of San Diego said Tuesday it had penned a deal with Chevron Research and Technology to study ways Illumina’s fiber-optic BeadArray microarray technology could be used to detect compounds in chemical plant operations.

Chevron, which is funding the study, expects to complete the research by early 2002. Chevron previously invested in Illumina through its venture capital group.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

At a meeting this week, researchers and others discussed the regulatory oversight needed for germline genome editing.

The US Food and Drug Administration has asked questions about Myriad Genetics' GeneSight test, according to Bloomberg.

Researchers report that neutrophil extracellular traps appear to binds gallstones together, according to New Scientist.

In Science this week: approach to infer genotype-by-environment interaction from genetic variants associated with phenotypic variability, and more.